What is ANGO's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.48B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ANGO?

P/E (TTM) is n/a and 52-week range is $9.39 to $16.29 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ANGO figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ANGO?

The company profile lists revenue (TTM) near $317M, net income (TTM) near $-3.64B, EPS (TTM) near $-0.89 when available from the market-data feed. Figures are informational and may lag live markets.

Where is AngioDynamics Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Latham, New York, US, 41.3M shares outstanding, ISIN US03475V1017 when available from company profile and filing metadata.

AngioDynamics Inc

$ANGO

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$11.52

+2.58%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 675 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The company designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.

Employees

675

Website

www.angiodynamics.com/

IPO

2004-05-27

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)